Sivell Christopher
Christopher Sivell, BN(Hons), is Hepatology Research Charge Nurse, Barts Health NHS Trust, Grahame Hayton Unit, Royal London Hospital, Whitechapel, United Kingdom.
Gastroenterol Nurs. 2019 Sep/Oct;42(5):428-434. doi: 10.1097/SGA.0000000000000443.
Nonalcoholic fatty liver disease is a growing condition among adolescent and adult populations, present in around 20%-30% of people in the United Kingdom. Nonalcoholic fatty liver disease is known as a silent disease and over many years may go on to cause nonalcoholic steatohepatitis. In the future it may become a leading contributor to cirrhosis, liver transplantation, and mortality. In recent years, programs have been set up to raise awareness of this condition with the first International NASH (nonalcoholic steatohepatitis) Day taking place in 2018; nevertheless, nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is still not clearly understood by many. An extensive review has shown a lack of nursing literature on this topic, and effective specialist nurse input for this patient group should be a key component in tackling this growing epidemic in the years to come.
非酒精性脂肪性肝病在青少年和成年人群中日益普遍，在英国约20%-30%的人群中存在。非酒精性脂肪性肝病被称为一种隐匿性疾病，多年后可能会发展为非酒精性脂肪性肝炎。未来，它可能成为肝硬化、肝移植和死亡的主要原因。近年来，已开展相关项目以提高对这种疾病的认识，2018年举办了首个国际非酒精性脂肪性肝炎日；然而，许多人对非酒精性脂肪性肝病和非酒精性脂肪性肝炎仍未完全了解。一项广泛的综述表明，关于这一主题的护理文献匮乏，未来几年，为该患者群体提供有效的专科护士服务应成为应对这一日益严重的流行病的关键组成部分。
